Stent for treatment of bifurcated lesions

• US 7,918,884 B2
• Filed: 06/08/2004
• Issued: 04/05/2011
• Est. Priority Date: 02/25/2003
• Status: Expired due to Fees

• Current Assignee: Cardinal Health Switzerland 515 GmbH (Cardinal Health, Inc.)
• Original Assignee: Cordis Corporation (Cardinal Health, Inc.)
• Inventors: Leon, Martin B., Park, Jin S., Burgermeister, Robert S., Krever, Matthew, Majercak, David C., Hojeibane, Hikmat
• Primary Examiner(s): Milano; Michael J
• Assistant Examiner(s): NGUYEN, VI X
• Application Number:
  US10/863,192
• Publication Number:
  US 20050288771A1
• Time in Patent Office: 2,492 Days
• Field of Search: 623/1.12, 623/1.15, 623/1.35, 623/1.16, 606/108, 606/194
• US Class Current: 623/1.15
• CPC Class Codes: A61F 2/856 Single tubular stent with a side portal passage
• CPC Class Codes: A61F 2/91 made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
• CPC Class Codes: A61F 2/915 with bands having a meander structure, adjacent bands being connected to each other
• CPC Class Codes: A61F 2002/821 Ostial stents
• CPC Class Codes: A61F 2002/91533 characterised by the phase between adjacent bands
• CPC Class Codes: A61F 2002/91558 connected peak to peak
• CPC Class Codes: A61F 2210/0004 bioabsorbable
• CPC Class Codes: A61F 2250/0067 Means for introducing or releasing pharmaceutical products into the body

Abstract

A stent includes a lattice defining a substantially cylindrical configuration having a proximal end portion and a distal end portion, and a middle portion between the proximal end and the distal end. The lattice being moveable from a crimped state to an expanded state, and a plurality of adjacent hoops. Each hoop has a plurality of adjacent loops. Additionally, the stent further includes a plurality of bridges connecting adjacent hoops and a plurality of extensions on the lattice. Each of the hoops and bridges define a cell. The proximal end portion and the distal end portion of the lattice have at least one cell respectively and the middle portion of the lattice has at least one cell. The plurality of extensions are on the middle portion of the lattice. The plurality of extensions are cantilevered projections from the bridges and/or hoops of the lattice. The plurality of extensions are movably deformable in a direction away from the lattice, for example, at least some of the extensions are movably deformable in a direction away from the bridges and at least some of the extensions are movably deformable in a direction away from the hoops.

Claims

1. A stent comprising:

a lattice defining a substantially cylindrical configuration having a proximal end section and a distal end section, and a middle section between the proximal end section and the distal end section, the lattice being movable from a crimped state to an expanded state, the lattice having a plurality of adjacent hoops;

a plurality of bridges connecting adjacent hoops;

a plurality of extensions on the lattice;

the extensions comprise a center arm terminating in a bifurcation;

each of the hoops and bridges defining a cell, the extensions having one end integrally formed with the lattice and another end extending into the cell; and

the proximal end section and the distal end section of the lattice having at least one cell respectively and the middle section of the lattice having at least one cell, the at least one cell of the middle section having spacing between adjacent hoops that is greater than spacing between adjacent hoops of the at least one cell of the proximal end section and the distal end section respectively.

2. The stent according to claim 1, wherein the plurality of extensions are on the middle section of the lattice.

3. The stent according to claim 2, wherein the plurality of extensions are cantilevered projections from the bridges of the lattice.

4. The stent according to claim 3, wherein the plurality of extensions are movably deformable in a direction away from the lattice.

5. The stent according to claim 4, wherein at least some of the extensions are movably deformable in a direction away from the bridges.

6. The stent according to claim 4, wherein one or more of the extensions comprise one or more arms extending from the bifurcation.

7. The stent according to claim 6, wherein one or more of the extensions comprise a first arm and a second arm extending from the bifurcation.

8. The stent according to claim 7, wherein the first arm is at a length shorter than the length of the second arm.

9. The stent according to claim 4, further comprising a drug on one or more portions of the lattice.

10. The stent according to claim 9, further comprising a drug and polymer combination on one or more portions of the lattice.

11. The stent according to claim 10, wherein the drug comprises rapamycin.

12. The stent according to claim 10, wherein the drug comprises paclitaxel.

13. The stent according to claim 4, wherein the stent is made of metal alloy.

14. The stent according to claim 4, wherein the stent is made of a superelastic material.

15. The stent according to claim 4, wherein the stent is made of a superelastic alloy.

16. The stent according to claim 4, wherein the stent is made of a polymeric material.

17. The stent according to claim 4, wherein the stent is made of a biodegradable polymer.

18. The stent according to claim 2, wherein at least some of the extensions are located on at least some of the hoops and are movably deformable in a direction away from the hoops.

19. The stent according to claim 1, wherein the bifurcation is shaped to receive the apex of an adjacent bridge in a crimped state.

20. The stent according to claim 1, wherein a plurality of cells having spacing between adjacent hoops that is greater than spacing between adjacent hoops of the at least one cell of the proximal end section and the distal end section, extending circumferentially around the middle section.